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Background:  Anti Neutrophil Cytoplasmic Antibodies (ANCA) are used to 
diagnose and monitor certain primary small vessel vasculitides.  The results are often 
nonspecific. ANCA testing guidelines and gating policies have been proposed to 
improve appropriate ordering and to discourage inappropriate use which often leads 
to erroneous diagnoses and dangerously improper immunosuppressive treatments. 
(Box1- display of case history of patient receiving inappropriate treatment based on positive ANCA serology) 
 
Methods:  Database with information on all consecutive ANCA requests at MU has been 
established beginning June 1st 2009(the date testing began at the MU ANA lab). Patients’ 
medical records in the first 3 months were reviewed to identify the indications for testing 
(table1). Clinical data on requests for the remainder of the year will be collected. Patient charts 
one year from the date of request will be reviewed to see if a diagnosis of vasculitis is made.                     
 
Results: 
Retrospective Analysis of ANCA Requests (Jun- Aug 2009) 
 Number Percentag
e 
 Total number of Requests 
 Requests for IF 
 Requests for ELISA 
127 
126 
1 
     
99.2 
0.8 
 
Analysis of all ANCA requests  
 Met testing guidelines                                            
 Did not meet guidelines 
 
32 
95 
 
25 
75 
Analysis of Requests which met testing guidelines- 
tabulation of indications, percentage (total = 32) 
1. Glomerulonephritis 
2. Pulmonary hemorrhage 
3. Cutaneous vasculitis 
4. Multiple lung nodules 
5. Destructive disease airways 
6. Long standing sinusitis/otitis 
7. Subglottic tracheal stenosis 
8. MMO/peripheral neuropathy 
9. Retroorbital mass 
10. Scleritis 
11. Sudden onset hearing loss 
12. Monitoring 
 
 
 
 
4 
9 
2 
1 
3 
3 
0 
4 
0 
3 
1 
2 
 
 
 
13 
28 
6 
3 
9 
9 
0 
13 
0 
9 
3 
6 
 
Conclusion: 75% of requests did not meet testing guidelines, deemed inappropriate. 
For quality improvement, data will be monitored and the information will be shared 
with the requesting physicians. Additional research will be performed on whether 
such education improves the test ordering patterns.  
 
 
